BioSpace News Archive

Business

Amunix Inks $1.5 Billion+ Licensing Deal with Roche

Amunix Pharmaceuticals, based in Mountain View, California, entered a licensing deal with Roche. Under the terms of the deal, Roche will pay Amunix $40 million upfront.

January 10, 2020
·
2 min read
·
Mark Terry
Business

California, Other States and Organizations Develop Schemes to Enter Generic Market and Drive Down Prices

The State of California is considering a measure to sell its own brand of generic drugs in an effort to get in on those cost-savings. California’s Gov. Gavin Newsom is expected to reveal the scheme today in his new state budget.

January 10, 2020
·
5 min read
·
Mark Terry
Drug Development

Moderna Sees Potential Blockbuster in Investigational Vaccine for Disease That Can Cause Birth Defects

Moderna Therapeutics is inching closer to becoming a commercial company and the company sees a potential blockbuster in an experimental treatment.

January 10, 2020
·
2 min read
·
Alex Keown
Pharm Country

Clinical Catch-Up: January 6-10, 2020

The first full business week of the new year began with plenty of clinical trial news. Here’s a look.

January 10, 2020
·
9 min read
·
Mark Terry
FDA

Blueprint Medicines Snags FDA Approval for First Precision Therapy for GIST Patients

Late Thursday, the U.S. Food and Drug Administration approved a new therapy to treat a rare mutation in patients with gastrointestinal stromal tumors.

January 10, 2020
·
2 min read
·
Alex Keown
Drug Development

Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion

Not waiting for the start of the annual J.P. Morgan Healthcare Conference, Eli Lilly announced it will acquire California-based Dermira, Inc. in an all-cash deal for $1.1 billion.

January 10, 2020
·
2 min read
·
Alex Keown
Drug Development

FDA to Pull Nearly 250 ANDAs, Continues to Revamp OND

With a new year underway, the U.S. Food and Drug Administration is doing some house-cleaning of sorts.

January 10, 2020
·
3 min read
·
Alex Keown
Drug Development

Job Cuts, Cancer Rates and Lawsuits: This Week’s News Roundup

As is often the case at the beginning and end of the year, a number of companies announced layoffs. Other news is related to lawsuits and an overall positive story about cancer death rates. Here’s a look.

January 10, 2020
·
4 min read
·
Mark Terry
Career Advice

The Top 20 Behavioral Interview Questions

Behavioral interviewing is probably the most popular interviewing style utilized today. Keeping this in mind we have listed some behavioral interview questions for you.

January 10, 2020
·
2 min read
·
Porschia Parker
Business

Neurocrine Biosciences and Idorsia Amend Option Agreement to License Novel Treatment for Rare Pediatric Epilepsy

Neurocrine Biosciences Owns Option to Exclusively License ACT-709478, a Clinical Stage Selective T-type Calcium Channel Blocker for the Treatment of Epilepsy

January 10, 2020
·
7 min read